Gefitinib in a molecularly defined chemonaive population with advanced non-small-cell lung cancer

被引：1
|
作者：
Teck, Lim Wan [1 ]
Huat, Tan Bee [1 ]
Ravindran, Kanesvaran [1 ]
Balram, Chowbay [1 ]
机构：
[1] Natl Canc Ctr S, Div Med Sci, Clin Pharmacol Lab, Humphrey Oei Inst Canc Res, Singapore 169610, Singapore
来源：
PHARMACOGENOMICS | 2008年 / 9卷 / 10期
关键词：
D O I：
10.2217/14622416.9.10.1381
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1381 / 1382
页数：2
相关论文
共 50 条
  • [41] Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status
    Gee-Chen Chang
    Kun-Chieh Chen
    Tsung-Ying Yang
    Ming-Chang Yin
    Ching-Pei Lin
    Benjamin Ing-Tiau Kuo
    Jeng-Yuan Hsu
    Investigational New Drugs, 2005, 23 : 73 - 77
  • [42] Use of Cetuximab After Failure of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
    Wu, Jenn-Yu
    Yang, Chih-Hsin
    Hsu, Ya-Chieh
    Yu, Chong-Jen
    Chang, Shih-Han
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    CLINICAL LUNG CANCER, 2010, 11 (04) : 257 - 263
  • [43] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Grossi, Francesco
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Defferrari, Carlotta
    Brianti, Annalisa
    Barletta, Giulia
    Genova, Carlo
    Murolo, Carmelina
    Cosso, Maurizio
    Fontanini, Gabriella
    Boldrini, Laura
    Truini, Mauro
    Pronzato, Paolo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1407 - 1412
  • [44] Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan
    Wang, Shiou-Han
    Yang, Chih-Hsin
    Chiu, Hsien-Ching
    Hu, Fu-Chang
    Chan, Chih-Chieh
    Liao, Yi-Hua
    Chen, Hsiao-Chin
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2011, 29 (01) : 13 - 18
  • [45] Unconvincing Benefit of Combination TherapyWith Gefitinib and Pemetrexed in Advanced Non-Small-Cell Lung Cancer
    Ota, Akiko
    Gyawali, Bishal
    Matsuoka, Ayumu
    Ando, Yuichi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06) : 691 - +
  • [46] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Francesco Grossi
    Erika Rijavec
    Maria Giovanna Dal Bello
    Carlotta Defferrari
    Annalisa Brianti
    Giulia Barletta
    Carlo Genova
    Carmelina Murolo
    Maurizio Cosso
    Gabriella Fontanini
    Laura Boldrini
    Mauro Truini
    Paolo Pronzato
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1407 - 1412
  • [47] Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    Tsurutani, J
    Dennis, PA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23): : 1795 - 1795
  • [48] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer - Reply
    Cappuzzo, F
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) : 462 - 463
  • [49] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [50] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
12345